pharmacopeia

Niobium

US-FDASourced from openFDA
GET
/api/v1/drug/niobium

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
1 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Arthralgia1100%
  2. 2Blister1100%
  3. 3Condition Aggravated1100%
  4. 4Gait Disturbance1100%
  5. 5Haemorrhage1100%
  6. 6Headache1100%
  7. 7Hyperkeratosis1100%
  8. 8Injection Site Mass1100%
  9. 9Injection Site Pain1100%
  10. 10Injection Site Thrombosis1100%
  11. 11Insomnia1100%
  12. 12Lipoma1100%
  13. 13Pain In Extremity1100%
  14. 14Pulmonary Pain1100%
  15. 15Skin Exfoliation1100%

Literature

View JSON

Recent PubMed references pinned to Niobium as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 4 most recently updated of 4 ClinicalTrials.gov registrations naming Niobium as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Note. Data for niobium is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients